Skip to main content
Gut Microbes logoLink to Gut Microbes
. 2020 Jun 24;11(6):1809–1823. doi: 10.1080/19490976.2020.1767463

Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice

Klytaimnistra Kiouptsi a,*, Giulia Pontarollo a,*, Hristo Todorov b,*,#, Johannes Braun a, Sven Jäckel a,c, Thomas Koeck a,c,d, Franziska Bayer a, Cornelia Karwot a, Angelica Karpi e, Susanne Gerber b,#, Yvonne Jansen f, Philipp Wild a,c,d, Wolfram Ruf a,c,g, Andreas Daiber c,e, Emiel Van Der Vorst f,h,i,j, Christian Weber f,h, Yvonne Döring f,h,k,*, Christoph Reinhardt a,c,✉,*
PMCID: PMC7524356  PMID: 32579470

ABSTRACT

The microbiota has been linked to the development of atherosclerosis, but the functional impact of these resident bacteria on the lesion size and cellular composition of atherosclerotic plaques in the aorta has never been experimentally addressed with the germ-free low-density lipoprotein receptor-deficient (Ldlr−/-) mouse atherosclerosis model. Here, we report that 16 weeks of high-fat diet (HFD) feeding of hypercholesterolemic Ldlr−/- mice at germ-free (GF) housing conditions did not impact relative aortic root plaque size, macrophage content, and necrotic core area. Likewise, we did not find changes in the relative aortic arch lesion size. However, late atherosclerotic GF Ldlr−/- mice had altered inflammatory plasma protein markers and reduced smooth muscle cell content in their atherosclerotic root plaques relative to CONV-R Ldlr−/- mice. Neither absolute nor relative aortic root or aortic arch plaque size correlated with age. Our analyses on GF Ldlr−/- mice did not reveal a significant contribution of the microbiota in late aortic atherosclerosis.

KEYWORDS: Microbiota, germ-free, low-density lipoprotein receptor-deficient mouse, atherosclerosis, aortic root, aortic arch, macrophages, smooth muscle cells, inflammatory markers, age, lesion size

Introduction

During the last decade, an increasing number of studies has provided a wealth of association-based1-3 and causal evidence,1,4-7 linking the microbiota and specific bacterial community members8-10 to the development of atherosclerotic lesions and cardiovascular disease (CVD) (for overview see Table 1).11 The gut microbiota has been recognized as an environmental factor that influences endothelial cell functions and contributes to vascular inflammatory phenotypes,1214 fostering arterial thrombosis through various prothrombotic mechanisms.1518 While experiments with germ-free (GF) apolipoprotein E (Apoe)-deficient mouse models at chow diet conditions have repeatedly shown a protective role of the microbiota in atherogenesis,4,6 it remains controversial how HFD and different feeding regimens affect atherosclerotic lesion development in mouse atherosclerosis models under GF housing conditions.

In a study that addressed late carotid artery atherosclerosis in the germ-free Ldlr−/- atherosclerotic mouse model,18 we have recently reported that 16 weeks of feeding with an adjusted calories diet (42% kcal from fat, 17.3% protein, 48.5% carbohydrates, 21.2% [wt/wt] fat, 0.2% cholesterol, 34% [wt/wt] sucrose) that had been vacuum packaged and irradiated, abolishes differences between GF and conventionally raised (CONV-R) mice in the lipoprotein profile and total plasma cholesterol levels, which are apparent characteristics observed under chow diet conditions.19,20 Although GF Ldlr−/- mice had reduced counts of adherent leukocytes to the uninjured common carotid artery lesion, absolute and relative carotid artery plaque size was unchanged by GF housing conditions. This was in contrast to plaque rupture-induced atherothrombosis and adhesion-induced platelet activation on type III collagen coatings, which were both diminished in germ-free Ldlr−/- mice relative to their CONV-R Ldlr−/- counterparts. Thus, our study on GF Ldlr−/- mice revealed a prothrombotic role of the gut microbiota in atherothrombosis, but unchanged carotid artery plaque size during late atherosclerosis.18

Since several reports demonstrated that the results on GF mouse atherosclerosis models vary dependent on the genetic model, the diet, and the feeding regimen (Table 1),46,18,22 we have comparatively analyzed the aortic lesions of GF Ldlr−/- and CONV-R Ldlr−/ mice to pinpoint whether the absence of the gut microbiota affects lesion size and cellular plaque composition.

Results

To study whether the lack of a gut microbiota impacts atherosclerotic lesion size and cellular composition, we rederived Ldlr−/- mice as germ-free (GF), kept those mice for 16 weeks on an irradiated high-fat diet (HFD) and compared their lesions in the aortic root and arch with those of conventionally raised (CONV-R) Ldlr−/- counterparts (Figure 1(a)). Histological analyses of fixed-frozen sections revealed no differences in the atherosclerotic plaque areas in the oil-red-O stained aortic roots of male and female, GF Ldlr−/- mice on HFD relative to CONV-R Ldlr−/- controls (Figure 1(b)). As expected, females in both HFD-fed CONV-R Ldlr−/- and HFD-fed GF Ldlr−/- groups had increased relative aortic root plaque areas compared to males, irrespectively of the presence of microbiota (Figure 1(c)).23,24 Thus, our results confirm that sex is a determinant of the atherosclerotic lesion size in ‘zero-level’ aortic roots.24 Interestingly, under these circumstances, germ-free housing conditions had no influence on aortic root lesion size.

Figure 1.

Figure 1.

(a) Applied diet regimen to study late atherosclerosis in GF and CONV-R Ldlr−/- mice. (b, c) Atherosclerotic plaque area in cross-sections at the zero-level of the aortic root of CONV-R (15 mice/group, 8 females, and 7 males) and GF (15 mice/group, 10 females, and 5 males) Ldlr−/- mice on HFD, (b) overall values or (c) sex-split. Mean ± SEM. Representative histology images showing Oil-Red O-stained sections. Scale bar 500 μm. (d) Quantification (% of total plaque nuclei) of MAC-2 positive cells in cross-sections of the aortic root (3–7 mice/group). Scale bar 200 μm. Mean ± SEM. Based on the % of plaque area, the necrotic core area was calculated for seven CONV-R and six GF mice, all males. (e) Quantification (% of total nuclei) of smooth muscle cells (SMC) by SMC-actin immunostaining in cross-sections of the aortic root (3–7 mice/group). Scale bar 200 μm. Mean ± SEM. (f, g) Immunostained atherosclerotic plaque area stained for 3-nitrotyrosine (3-NT) in cross-sections at the zero-level of the aortic root of CONV-R (8 mice/group, four females and four males) and GF (8 mice/group, four females, and four males) Ldlr−/- mice on HFD, (f) overall values, or (g) sex-split. Mean ± SEM. Representative histology images showing 3-NT-stained sections. Scale bar 500 μm. Independent samples Student’s t-tests, * p < .05, ** p < .01, *** p < .001. For all panels, CONV-R mice are shown in gray and GF mice in white. For panels (b, c, and f, g), the sex of the mice is color-coded: females: red; males: blue.

Next, we comparatively analyzed the cellular composition of aortic root lesions in GF and CONV-R Ldlr−/- mice on HFD. Immunostaining of aortic root plaques for the macrophage marker MAC-2 excluded differences in the macrophage content or the necrotic core area in these late atherosclerotic lesions, which was comparable between the two groups of mice (Figure 1(d)). Interestingly, smooth muscle actin staining revealed reduced quantities of smooth muscle cells in the aortic root plaques of GF Ldlr−/- mice relative to CONV-R Ldlr−/- mice (Figure 1(e)), in agreement with the fibroproliferative response in aortic root lesions that we observed in HFD-fed GF Ldlr−/- mice compared with CONV-R Ldlr−/- mice. In line with unchanged macrophage content, reactive nitrogen species (RNS) levels in aortic root plaques were comparable between the HFD-fed GF Ldlr−/- mice and CONV-R Ldlr−/- mice (Figure 1(f)), as indicated by unchanged areas of 3-nitrotyrosine (3-NT) immunostaining (Figure 1(g)). In conclusion, germ-free housing conditions influenced smooth muscle cell content in aortic root lesions, but did not result in altered macrophage content or changed RNS levels.

In addition, we analyzed the aortic arch plaque areas in hematoxylin-and-eosin (HE)-stained cryosections, but did not find differences between HFD-fed GF Ldlr−/- mice relative to HFD-fed CONV-R Ldlr−/- mice (Figure 2(a)). Furthermore, analyzing the aortic arch plaque areas, we did not find differences in relative plaque size between female and male Ldlr−/- mice (Figure 2(b)). In contrast to aortic root plaque size,24 sex did not influence lesion size in the aortic arch of late atherosclerotic plaques in Ldlr−/- mice.

Figure 2.

Figure 2.

Atherosclerotic plaque area in longitudinal-sections at the aortic arch of CONV-R (16 mice/group, 12 females, and 4 males) and GF (21 mice/group, 14 females, and 7 males) Ldlr−/- mice on HFD, (a) overall values, or (b) sex-split. Mean ± SEM. Representative histology of hematoxylin and eosin-stained sections. Scale bar 1 mm. CONV-R mice are shown as gray dots, and GF animals as white dots. The sex of the mice is color-coded: females: red; males: blue.

In order to examine the influence of age on aortic plaque size, we calculated the Pearson correlation between age and plaque size. The age of the Ldlr−/- mice at the time of sacrifice following the 16 weeks HFD-feeding regimen was not significantly correlated with absolute or relative plaque size in the aortic root overall and when animals were stratified by sex (Figure 3(a)). Aortic arch plaque area was also not dependent on the age of the mice (Figure 3(b)). It is well established that age has a strong influence on aortic root atherosclerosis. To further investigate if age impacted aortic root and aortic arch lesion size, we performed a 2-way analysis of covariance (ANCOVA) with GF or CONV-R housing conditions and sex as factors and age as covariate. The effect of age was not statistically significant (F1,33 = 1.31, p = .259 for aortic root lesion size and F1,35 = 0.716, p = .403 for aortic arch lesion size). Furthermore, the difference between GF Ldlr-/- and CONV R Ldlr−/- in aortic root plaque size (F1,33 = 1.141, p = .293) or in aortic arch plaque size (F1,35 = 0.21, p = .649) was not significant even after adjusting for age differences.

Figure 3.

Figure 3.

Correlation between the age and the absolute (µm2) or relative (%) plaque size at the (a) zero-level of the aortic root or (b) at the aortic arch in CONV-R and GF Ldlr−/- mice on HFD. The groups of mice are the same as detailed in Figures 1 and 2. For all panels, CONV-R mice are shown as gray dots, and GF animals as white dots. The sex of the mice is color-coded: females: red; males: blue.

Since our previous study identified altered plasma cytokine levels between HFD-fed GF Ldlr−/- and CONV R Ldlr−/- mice,18 we went on to identify additional biomarkers influenced by colonization with microbiota under normal and HFD conditions. We analyzed 92 proteins of the Mouse Exploratory Panel (Olink Proteomics AB, Uppsala, Sweden) in citrated plasma samples by an immuno-PCR-based proximity extension assay with high sensitivity to detect low-level proteins. Principal component analysis showed robust clustering of the individual samples according to experimental conditions (Figure 4(a)). The greatest difference was observed for the profiles of HFD-fed Ldlr−/- mice compared to WT mice on a chow diet. However, the microbiome status separately affected the analytes measured by proximity ligations assay. We fit the data of HFD-fed Ldlr−/- mice with housing conditions as a factor to model the difference in plasma proteins induced by GF conditions. This allowed us to identify markers that were altered in HFD-fed Ldlr−/- mice in dependence of the microbiota (Figure 4(b)). Analogously, we identified a set of markers that were altered in GF WT mice in comparison to CONV-R WT mice (Figure 4(c)). The altered biomarkers had no apparent enrichment in specific GO terms.

Figure 4.

Figure 4.

(a) Principal component analysis of plasma proteome changes in GF WT, GF Ldlr−/-, CONV-R WT, and CONV-R Ldlr−/- mice. Scatter plot of the first two principal components for all 92 analytes measured in the indicated mice and feeding as well as colonization conditions. Each point represents a biological replicate from independent animals. (b) Volcano plot of the differential abundance of circulating biomarkers in HFD-fed GF Ldlr−/- mice compared to HFD-fed CONV-R Ldlr−/- mice and (c) GF WT mice compared to CONV-R WT mice. Positive log2 fold change values correspond to higher protein levels and negative values correspond to reduced protein levels in GF condition mice. The horizontal line reflects the cutoff for statistical significance (p < 0.05) while vertical lines represent threshold for minimum effect size (|log2 fold change| >0.5). Red highlights proteins with a significant difference (p < 0.05) above the threshold for effect size. Grey dots represent proteins with either no statistical significance or small effect size or both.

A set of markers were concordantly altered under HFD and normal diet. Interleukin 23 receptor (IL23r) was decreased whereas epithelial cell markers, such as epithelial cell adhesion molecule (EPCAM), and the incretin glucagon-like peptide-1 (Glp-1, Gcg) with vascular protective functions were increased in the absence of microbiota irrespectively of the diet and the genotype. In contrast, microbiota had also differential effects when comparing WT mice on a normal diet with Ldlr−/- mice on an HFD. Specifically, under HFD inflammation markers, e.g. tumor necrosis factor (Tnf), interleukin 1 alpha (IL1a), glial cell derived neurotrophic factor family receptor alpha 1 (Gfra1), and C-X-C motif chemokine ligand 9 (Cxcl9), as well as follistatin (Fst) levels, were reduced in GF Ldlr-/- mice relative to their CONV-R counterparts. In addition, proteins known to be expressed in the gastrointestinal track, i.e. integrin subunit beta 6 (Itgb6) and v-set and immunoglobulin domain containing 2 (Vsig2) were increased, possibly related to changes in gut permeability. GF HFD Ldlr−/- mice also had higher markers associated with metabolic processes, e.g. carbonic anhydrase 13 (Ca13), quinoid dihydropteridine reductase (Qdpr), mitogen-activated protien kinase 6 (Map2k6), Axin1, which in part may be related to differences in the formulation of the diet independent of lipid content. Interestingly, the downregulation of interleukin 17a/f (IL17a/f) in response to loss of the gut microbiota in GF WT mice was no longer seen in GF HFD-fed Ldlr−/- mice. While macrophage densities were not changed in late atherosclerotic lesions, these proteome changes indicate that GF conditions nevertheless alter immune cell activation or polarization in atherosclerotic mice.

Discussion

More than one century ago, in 1910, in his book “The Prolongation of Life. Optimistic Studies” Ilja Metchnikoff proposed that “auto-toxication from microbial poisons absorbed and microbes themselves may pass through the walls of the intestine and enter the blood” and he discussed the poisons of microbes as one possible cause for the development of inflammatory artery lesions.25 Metchnikoff clearly recognized chronic inflammation, triggered by resident microbes, as one of the causes that endangers vascular health and restricts human lifespan. In recent years, this hypothesis from 1910 was refurbished, as it now could be experimentally addressed thanks to genome-wide sequencing approaches and the depletion of gut microbiota in mouse models of atherosclerosis. While the development of next-generation sequencing enabled the detection of abundant bacterial species in atherosclerotic patients,2 decimation of the gut microbiota by antibiotic treatments, and/or analysis of germ-free atherosclerotic mouse models unravel the global impact of the resident bacterial community on the host.6,7,20 In our recent work, we analyzed carotid artery atherosclerosis and atherothrombosis evoked by ultrasound-induced rupture of carotid artery plaques in the germ-free Ldlr−/- mouse model kept for 16 weeks on HFD.18 We found a phenotype of decreased adhesion-induced platelet activation in the GF Ldlr−/- mice. Clearly, with regard to the microbiota’s influence on the development of atherosclerotic lesions, controversies persist. In part, experiments may yield divergent results due to different mouse atherosclerosis models studied, inappropriate comparison of GF status with antibiotic decimation of commensals, variations in feeding regimens, time point of diet switch, and the analysis of different endpoints (Table 1). For this reason, detailed reports on atherosclerotic phenotypes with gnotobiotic mouse atherosclerosis models are timely and required to achieve a complete picture on the contribution of the microbiota to atherogenesis. In this addendum article, we provide additional information on atherosclerotic lesion formation at the aortic root and the aortic arch, comparing the same group of GF Ldlr−/- mice with their CONV-R Ldlr−/- counterparts, kept for 16 weeks on irradiated HFD.18

Table 1.

Studies with antibiotics and germ-free mouse models addressing the functional implication of the microbiota in atherogenesis.

Antibiotic (Abx) microbiota depletion
Study design Mouse model Start End Diets (producer) Abx Treatment Results Ref
Chow diet, choline/TMAO-rich diet,
HFD:
SPF vs Abx
Apoe−/-
males+females
C57BL/6 J
4–8
weeks
20–24
weeks
  • Chow diet: normal chow, 0.08–0.09% choline (2018)

  • Choline-rich diet: chow+0.5% or 1.0% (TD.07863, TD.078634)

  • TMAO-rich: chow+0.12%(TD.07865)

  • HFD: 42% fat, 0.15% cholesterol (88137). All diets were from Teklad.

Abx in the drinking water for 3 weeks.
(1.0 g/L ampicillin, 1 g/L neomycin sulfate, 0.5 g/L vancomycin, 1 g/L metronidazole)
  • Choline/TMAO-rich diet effects: increased aortic root atherosclerotic plaque area. Similar cholesterol, triglycerides and glucose levels. Enhanced athero-sclerosis in female mice (even on normal chow diet).

  • Abx effects: reduced atherosclerosis; lower macrophage cholesterol accumulation; gut microbiota and dietary choline increase TMAO production.

Wang Z, Nature., 20111
HFD:
SPF vs Abx
Ldlr−/-
males+females
- background
10 weeks 26 weeks
  • HFD: 0.15% cholesterol, 21% fat, 19.5% casein (WD, TD88137, Harlan Teklad)

Abx in the drinking water.
(100 mg/L neomycin, 10 mg/L polymyxin B).
  • Abx effects: decreased atherosclerotic lesion size in aortic arch and entire aorta; smaller necrotic core; no effects on plasma cholesterol and triglyceride levels; attenuation of glucose intolerance and LPS uptake.

Ghosh SS, PLoS One., 201426
HFD without gluten ± gladin:
SPF vs Abx
Apoetm1Unc/N11
females
B6.129P2
at birth 16 weeks
  • HFD without gluten (D12079B, Research Diet Inc.)

  • HFD without gluten + 1% gliadin (D11061501, Research Diet Inc.)

Abx in the drinking water.
(1 g/L ampicillin)
  • Abx effects: decreased aortic atherosclerotic lesion size; improvement of glucose tolerance and reduced insulin levels; reduced LDL, VLDL cholesterol levels.

  • Gluten-free diet effects: no significant effects.

Rune I, PloS One., 201621
Chow diet:
SPF vs Abx
vs CONV-D
Apoe−/-, Ldlr−/-
females
C57BL/6 J
4 weeks 8/16 weeks
  • Chow diet: regular (RM1, Dietex)

Abx 4 weeks daily gavage.
(200 mg/kg neomycin, 200 mg/kg metronidazole, 200 mg/kg ampicillin, 100 mg/kg vancomycin).
  • Abx effects: increased plasma cholesterol (+55%), VLDL (+53%) and LDL (+36%) levels in microbiota-depleted mice (due to increased cholesterol absorption, hepatic synthesis and clearance).

Le Roy T, BMC Biol., 201927
Chow diet, HFD:
SPF vs Abx
Apoetm1Unc/J
males
B6.129P2
6 weeks 22 weeks
  • Chow diet: 10% calories from fat (GLP Mucedola Srl)

  • HFD: 45% calories from fat (D12079B, Research Diets)

Abx in the drinking water after 6 weeks of feeding.
(1 g/L ampicillin, 1 g/L metronidazol, 1 g/L neomycin, 0.5 g/L vancomycin).
  • Abx effects: increased aortic root atherosclerotic lesion size (via tryptophan and lipid metabolism and reduction of Bacteroidetes and Clostridia).

  • HFD effects: no significant effects.

Kappel BA, Mol Metabol. 20207
Chow diet, HFD: Ldlr−/-(Casp1−/-) vs
Ldlr−/-(Ldlr−/-)
female Casp1−/- B6 N.129S2
female Ldlr−/-
B6.129S7
12 weeks
20/25 weeks
  • Chow diet: (RMH-BAB diets)

  • HFD: (HFC, Research Diets)


Abx 10 d oral gavage.
(0.26 mg/g ampicillin, 0.1 mg/g metronidazol, 0.26 mg/g neomycin, 0.13 mg/g vancomycin).
  • Effect of Casp1−/- fecal translplantation into Ldlr−/- mice: similar aortic root atherosclerotic lesion size after 8 weeks, but 29% increase after 13 weeks HFD.

  • Abx effects: increase of proinflammatory phenotype.


Brandsma E, Circ Res., 201928
Germ-free mice (GF)
Study design
Mouse model
Start
End
Diets (producer)
Results
Ref
HFD:
SPF vs GF
Apoe−/-/lpsd
males+females
C57BL
4 weeks 22/32 weeks
  • HFD: 0.15% cholesterol, 21.22% fat, 17.01% protein, 48.48% carbohydrate


(TD88137, Harlan Teklad)
  • GF housing effects: no differences in atherosclerotic lesion sizes in the aortic root between GF and CONV-R mice; similar plasma lipid profiles and cholesterol. No effect of gnotobiosis (and infectious agents) on the progress of atherosclerosis: HFD is sufficient for atherogenesis. No sex effects.

Wright SD,
J Exp Med, 200022
Chow diet, HFD:
SPF vs GF vs CONV-D.
Apoetm1Unc/J
males+females
C57BL/6
8 weeks 24 weeks
  • Chow diet: ST-1 (Bergman, Kocanda)

  • HFD: 2% cholesterol, 5% tallow fat, 3% fat fish meal

  • GF housing effects: bigger atherosclerotic lesion sizes in the aorta (lipids deposition with foam cells and macrophages) and higher cholesterol levels.

  • Diet effects: under chow diet, only GF mice developed atherosclerotic lesions in the aorta. Fed HFD, atherosclerosis was similar in GF and CONV-R.

Stepankova R,
J Ather Thromb 20104
Chow diet:
SPF vs GF
Apoe−/-
all females
C57BL/6
not
specified
20 weeks
  • Chow diet: 20% calories from fat, 50% from carbo-hydrate, 30% from protein (CMF, Oriental Yeast Co).

  • GF housing effects: reduction in atherosclerotic lesion formation (due to reduced LPS-mediated inflammatory response) and lipid area in the aortic root, with a reduction of intraplaque macrophages. Higher plasma and hepatic cholesterol levels; higher VLDL and LDL-cholesterol; lower triglycerides.

Kasahara K, J Lipid Res., 20175
Chow diet, HFD:
SPF vs GF
Apoe−/-
males+females
C57BL/6 J
8
weeks
20 weeks
  • Chow diet: chow (Envigo TD.130104) or chow +1,2% choline (Envigo TD.09041).

  • HFD: HFD (D11042101; Research Diets) + or HFD + 1% choline (D11042102; Research Diets)

  • GF housing effects: bigger aortic atherosclerotic lesion sizes in the aorta and higher cholesterol levels.

  • Diet effects: differences are abolished in HFD conditions. No effect of choline supplementation on aortic lesion sites.

Lindskog Jonsson A, ATVB, 20186

Similar to recent work on germ-free Apoe-deficient mice kept on an atherogenic HFD,6 our study on GF Ldlr−/- mice did not find an impact of the gut microbiota on atherosclerotic lesion size, neither in the aortic root, nor in the aortic arch. These results are consistent with unchanged carotid artery lesion areas in 16 weeks HFD-fed GF Ldlr−/- mice relative to CONV-R Ldlr−/- mice, reported in our previous study, implicating the microbiota in atherothrombosis and adhesion-induced platelet activation.18 While in this study we found increased total plasma cholesterol levels and increased lipoprotein levels in GF Ldlr−/- mice on a chow diet, which is due to the microbiota’s role in cholesterol excretion,20 the lipoprotein profile was unchanged at conditions of excess cholesterol from the diet (0.2% cholesterol). In particular, at conditions of limited cholesterol in the diet, the microbiota has a critical role in the deconjugation, dehydroxylation, and oxidation of primary bile acids, thus promoting their excretion.2933 On the other hand, the relatively high cholesterol content of the HFD used in our study and the late endpoints of the analyses could in principle explain why there was no difference in aortic root and aortic arch lesion size between HFD-fed GF Ldlr−/- mice and CONV-R Ldlr−/- mice.

It is well established that the dietary cholesterol content strongly influences aortic root lesion size.23 Hence, the dietary cholesterol content and the applied feeding regimen may influence the extent of atherosclerosis in terms of plaque size and cellular plaque composition with respect to the analyzed vascular bed. This may at least in part explain the seemingly controversial data of different mouse atherosclerosis studies addressing the role of the microbiota in atherogenesis (Table 1).1,4-6,18,21,22,34 In late atherosclerosis, at 14 weeks of HFD feeding, female Ldlr−/- mice kept on the same HFD we used in our studies show significantly increased total cholesterol levels, low-density lipoprotein cholesterol, and significantly reduced relative aortic root lesions compared with age-matched male Ldlr−/- mice.24 Likewise, larger lesion areas were reported in young female Apoe−/- mice on chow diet at the age of 16 weeks compared with age-matched male Apoe−/- mice.35 Increased lesion area was also found by en face aorta analyses.36 Altogether, these studies indicate that in addition to the genetic mouse atherosclerosis model, the dietary cholesterol content, sex, and the chosen endpoint of the feeding regimen are pivotal for the conclusions drawn from functional microbiome studies on atherosclerosis.

Of note, our study did not exclude that specific microbes could impact atherogenesis. Diet has a dominant influence in shaping the diversity and composition of the gut microbial ecosystem.18 As metagenomics studies have identified specific taxa2,3,37-39 and as there is ample experimental evidence suggesting that microbiota composition may significantly influence the development of atherosclerotic lesions,9,40 future functional microbiome studies should aim to understand how specific diets affect the abundance of specific gut microbes linked to atherosclerosis. Similar to the selective inhibition of trimethylamine (TMA)-lyase enzymes of gut microbes associated with atherosclerosis,39 this may lead to new pharmacologic interventions that may prevent atherogenesis by targeting specific metabolic functions of gut microbes.40 Furthermore, there certainly is a need for in-depth knowledge on the protective role of some community members and the dietary conditions that increase their relative abundance.9,10

In addition to specific bacteria, also certain microbial-associated molecular patterns (MAMPs) were recognized to contribute to chronic inflammation, driving atherogenesis by influencing different leukocyte subsets.4143 Studies with germ-free mouse models have revealed that gut microbiota-derived compounds promote steady-state granulopoiesis and regulate the lifespan of neutrophils and inflammatory monocytes.4446 In our study on hyperlipidemic Ldlr−/- mice, we could confirm the influence of the gut microbiota, as total leukocyte counts and in particular the proportion of monocytes and neutrophils were significantly reduced, whereas we found a slight increase in the proportion of lymphocytes in GF Ldlr−/- mice.18 This was also reflected by reduced counts of rolling and adherent leukocytes at the uninjured carotid artery lesion. Unexpectedly, the observed reduction in blood monocytes in the blood of GF Ldlr−/- mice on an HFD was not associated with diminished macrophage content in the aortic root lesions or with a smaller necrotic core area, but this might be due to the high cholesterol content of the HFD and the late time point analyzed (16 weeks). In support of a reduced fibroproliferative response, we found reduced numbers of vascular smooth muscle cells but unchanged staining of the vascular RNS marker 3-NT in the aortic root plaques. This is in accordance with previous work that did not detect changed vascular superoxide formation, comparing dihydroethidium staining in the aorta of unchallenged GF to CONV-R C57BL/6 WT mice.13 Hence, in future studies, it will be interesting to explore if the absence of a gut microbiota influences the expression of growth factors in the developing atherosclerotic lesions, thus affecting the migration and proliferation of vascular smooth muscle cells.47 In line with the lower number of vascular smooth muscle cells, plasma follistatin (Fst) levels were reduced in HFD-fed GF Ldlr−/- mice compared to their CONV-R counterparts.48 In contrast to WT mice on a normal diet, inflammation markers Tnf, IL1a, and Cxcl9 were downregulated in HFD-fed GF Ldlr−/- mice compared to HFD-fed CONV-R Ldlr−/- mice. Thus, despite unaltered macrophage numbers in the atherosclerotic lesions, GF mice display reduced inflammation detected by circulating markers.

In addition, we detected a reduction of Gfra1 in GF Ldlr−/- mice. Recently it has been shown that low Gfra1 levels result in enterocolitis with abnormal mucin production and retention causing epithelial damage.49 Conversely, lack of microbiota increases circulating markers of proteins that are expected to be expressed in the intestine in HFD-fed GF Ldlr−/- mice. It will be of interest whether such unexpected markers reflect changes in gut permeability that are influenced not only by commensal microbiota but also HFD.

Therefore, future work should explain if the observed differences in vascular smooth muscle cell content in the aortic root plaques are related to increased collagen synthesis and if this also applies to carotid artery plaques.50 This aspect is of particular relevance, since vascular smooth muscle cell-derived collagen fibers could promote plaque rupture-induced atherothrombosis and adhesion-dependent platelet activation, as indicated by increased phosphatidylserine exposure in HFD-fed CONV-R Ldlr−/- mice relative to HFD-fed GF Ldlr−/- mice.18,20 To grasp the influence of the microbiome on cellular plaque composition during atherogenesis, a time-course analysis of atherosclerotic lesion development with a well-defined feeding regimen on gnotobiotic atherosclerosis mouse models is required.

Age is believed to strongly impact the pathogenesis of aortic atherosclerosis. Therefore, previous experimental studies, investigating the effect of microbiota on atherosclerotic lesion development, have used age-matched animals.1,4,6 In contrast, our study included mice of varying age at the start of HFD. Importantly, age was not significantly correlated with absolute and relative plaque size in the aortic root and aortic arch. Additionally, the effect of GF housing conditions was not significant even after accounting for age differences. Thus, our study provides statistical evidence that conflicting results on the role of microbiota on atherogenesis might stem from factors other than age. However, it is important to mention that our results might be attributable to the late time point analyzed. Additional studies with animals of wider age range or a systematic meta-analysis of existing reports would be instrumental to resolve the complex interaction of age, diet, and gut microbiota on the development of atherosclerotic lesions.

Materials and methods

Animals – B6.129S7Ldlrtm1Her/J mice (1) (Ldlr−/- mice) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA) and were treated as previously described. Briefly, Ldlr−/- mice were rederived as germ-free (GF) by aseptic hysterectomy. Ldlr−/- and WT mice on a C57BL/6 J background were maintained as a GF mouse colony in sterile flexible film mouse isolator systems checking weekly for the germ-free status of the mice by detection of 16S rDNA by PCR and by bacterial culture. All experimental animals were 4–14 weeks old male or female mice housed in the Translational Animal Research Center (TARC) of the University Medical Center Mainz under specific pathogen-free (SPF, CONV-R) or GF conditions in EU type II cages with 2–5 cage companions with standard autoclaved lab diet and water ad libitum, 22 ± 2°C room temperature and a 12 h light/dark cycle. All groups of mice were free of clinical symptoms. All procedures performed on mice were approved by the local committee on legislation on protection of animals (Landesuntersuchungsamt Rheinland-Pfalz, Koblenz, Germany; 23177–07/G12-1-100; 23 177–07/G 16-1-013).

Treatment of mice

Ldlr−/- mice were fed for 16 weeks with an adjusted calories diet (42% from fat, vacuum-packaged, irradiated, and microbial analyzed, TD.88137, Envigo, Venray, the Netherlands).

Analysis of atherosclerotic lesions

For analysis of mouse atherosclerotic lesions, the aortic roots at zero-level were stained for lipid depositions with Oil-Red-O or HE (hematoxylin-and-eosin) staining. In brief, hearts with aortic root were embedded in Tissue-Tek O.C.T. compound (Sakura) for cryo-sectioning. Atherosclerotic lesions were quantified in 5 µm transverse sections and averages were calculated from 3 to 5 sections for each mouse. For analysis of the cellular composition or inflammation of atherosclerotic lesions, sections were stained with an antibody to MAC2 (AbD Serotec), or SMA (Dako), Nuclei were counter-stained by 4ʹ,6-Diamidino-2-phenylindol (DAPI). After incubation with a secondary FITC- or Cy3-conjugated antibody (Life Technologies), sections were analyzed using a Leica DMLB fluorescence microscope and charge-coupled device (CCD) camera. Blinded image analysis was performed using Diskus, Leica Qwin Imaging (Leica Lt.) or Image J software. For each mouse and staining, 2–3 root sections were analyzed and data were averaged.

3-Nitrotyrosine immunostaining

The cryosections were dried at 37°C for 1 h, then fixed at −20°C in acetone for 10 minutes. To block the nonspecific bindings, the sections were incubated with 2.5% horse normal serum (Vector laboratories, Burlingame, CA94010) for 60 minutes. Sections were stained for 3-nitrotyrosine made in rabbit (Millipore, Germany) diluted 1:100 in antibody dilution medium (Agilent, Germany) overnight. Following the species of primary antibody, an appropriate biotinylated secondary antibody was used following the manufacturer’s instructions. For immunochemical detection ABC reagent (Vector) and then DAB reagent (Peroxidase substrate Kit, Vector) as substrate were used.

Proximity ligation assay

Simultaneous-targeted protein profiling of 92 proteins of the Mouse Exploratory panel (Olink Proteomics AB, Uppsala, Sweden) was performed in 1 µl of once-thawed citrate anticoagulated plasma samples by real-time PCR using the Fluidigm BioMarkTM HD real-time PCR platform based on multiplexing proximity extension assay (PEA) technology (Olink Proteomics AB).51 For exploratory data analysis, a principal component analysis of the Olink NPX values was performed using the R version 3.6.3 prcomp() function. A linear model was fitted to all data for individual Ldlr−/- mice or WT respectively with housing condition as a factor to model the effect of GF conditions using the R version 3.6.3 lm() function. Log2 fold changes and associated p-values were calculated by Student’s t-test and returned by the summary function of the R lm fit object. P-values less than 0.05 were considered statistically significant.

Statistical analysis

Data are presented as mean ± SEM and/or individual data points. Statistical calculations were performed with GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA, US) using the independent samples Student’s t-test to compare two groups. Pearson correlation coefficients and 2-way ANCOVA were calculated with R version 3.5.3 (R Core Team, Austria, Vienna). P-values less than 0.05 were considered statistically significant.

Supplementary Material

Supplemental Material

Acknowledgments

We are grateful to Klaus-Peter Derreth for expert technical assistance.

Funding Statement

The project was funded by the CTH Junior Group Translational Research in Thrombosis and Hemostasis (BMBF 01EO1003 and 01EO1503), by the German Center for Cardiovascular Research (DZHK, Pillar B Project, FKZ 81 × 2210106 to C.R., Y.D., and C.W.), by a project grant from the Boehringer Ingelheim Foundation (Consortium Grant “Novel and neglected cardiovascular risk factors”) to C.R. and WR, by a project grant from the Naturwissenschaftlich-Medizinisches Forschungszentrum (NMFZ) to C.R., by the European Research Council (ERC AdG °692511) to C.W. Supported by a grant from the Interdisciplinary Center for Clinical Research within the faculty of Medicine at the RWTH Aachen University, and NWO-ZonMw Veni (91619053) to E.P.C.v.d.V. S.J., Y.D., and C.R. are members of Young DZHK. W.R. is PI of the DZHK. The work of G.P. was supported by an EMBO Short Term Fellowship (No. 7605) and by an intramural Stufe1 project grant (Inneruniversitäre Forschungsförderung).

Author Contributions

K.K., S.J., C.K., T.K., Y.J., Y.D., and C.R. performed experiments and analyzed data. K.K., G.P., H.T., J.B., S.J., F.B., Y.J., S.G., P.W., W.R., A.D., E.v.d.V., C.W., and Y.D. analyzed data. K.K., G.P., and H.T. participated in manuscript writing. Y.D. and C.R. designed experiments and wrote the manuscript.

Disclosure of Potential Conflicts of Interest

The authors declare that no conflicts of interest exist.

Supplementary material

Supplemental data for this article can be accessed on the publisher’s website.

References

  • 1.Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57–63. doi: 10.1038/natore09922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA. 2011;108(Suppl.1):4592–4598. doi: 10.1073/pnas.1011383107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, Bäckhed F, Nielsen J.. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012;3:1245. doi: 10.1038/ncomms2266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Stepankova R, Tonar Z, Bartova J, Nedorost L, Rossman P, Poledne R, Schwarzer M, Tlaskalova-Hogenova H. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb. 2010;17:796–804. doi: 10.5551/jat.3285. [DOI] [PubMed] [Google Scholar]
  • 5.Kasahara K, Tanoue T, Yamashita T, Yodoi K, Matsumoto T, Emoto T, Mizoguchi T, Hayashi T, Kitano N, Sasaki N, et al. Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis. J Lipid Res. 2017;58:519–528. doi: 10.1194/jlr.M072165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lindskog Jonsson A, Caesar R, Akrami R, Reinhardt C, Fåk Hållenius F, Borén J, Bäckhed F. Impact of gut microbiota and diet on the development of atherosclerosis in Apoe−/- mice. Arterioscler Thromb Vasc Biol. 2018;38:2318–2326. doi: 10.1161/ATVBAHA.118.311233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kappel BA, de Angelis L, Heiser M, Ballanti M, Stoehr R, Goettsch C, Mavilio M, Artati A, Paoluzi OA, Adamski J, et al. Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment. Mol Metabol. 2020;36:100976. doi: 10.1016/j.molmet.2020.100976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kühbacher T, Nikolaus S, Namsolleck P, Blaut M, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation. 2006;113:929–937. doi: 10.1161/CIRCULATIONAHA.1005.579979. [DOI] [PubMed] [Google Scholar]
  • 9.Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe-/- mice. Circulation. 2016;133:2434–2446. doi: 10.1161/CIRCULATIONAHA.115.019645. [DOI] [PubMed] [Google Scholar]
  • 10.Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, Mehrabian M, Denu JM, Bäckhed F, Lusis AJ, et al. Interactions between Reoseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol. 2018;3:1461–1471. doi: 10.1038/s41564-018-0272-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ascher S, Reinhardt C. The gut microbiota: an emerging risk factor for cardiovascular and cerebrovascular disease. Eur J Immunol. 2018;48:564–575. doi: 10.1002/eji.201646879. [DOI] [PubMed] [Google Scholar]
  • 12.Reinhardt C, Bergentall M, Greiner TU, Schaffner F, Ostergren-Lundén G, Petersen LC, Ruf W, Bäckhed F. Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature. 2012;483:627–631. doi: 10.1038/nature10893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Karbach SH, Schönfelder T, Brandão I, Wilms E, Hörmann N, Jäckel S, Schüler R, Finger S, Knorr M, Lagrange J, et al. Gut microbiota promote angiotensin II-induced arterial hypertension and vascular dysfunction. J Am Heart Assoc. 2016;5:e003698. doi: 10.1161/JAHA.116.003698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wun K, Theriault BR, Pierre JF, Chen EB, Leone VA, Harris KG, Xiong L, Jiang Q, Spedale M, Eskandari OM, et al. Microbiota control acute arterial inflammation and neointimal hyperplasia development after arterial injury. PLoS One. 2018;13:e0208426. doi: 10.1371/journal.pone.0208426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165:111–124. doi: 10.1016/j.cell.2016.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jäckel S, Kiouptsi K, Lillich M, Hendrikx T, Khandagale A, Kollar B, Hörmann N, Reiss C, Subramaniam S, Wilms E, et al. Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2. Blood. 2017;130:542–553. doi: 10.1182/blood-2016-11-754416. [DOI] [PubMed] [Google Scholar]
  • 17.Roberts AB, Gu X, Buffa JA, Hurd AG, Wang Z, Zhu W, Gupta N, Skye SM, Cody DB, Levison BS, et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med. 2018;24:1407–1417. doi: 10.1038/s41591-018-0128-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kiouptsi K, Jäckel S, Pontarollo G, Grill A, Kuijpers MJE, Wilms E, Weber C, Sommer F, Nagy M, Neideck C, et al. The microbiota promotes arterial thrombosis in low-density lipoprotein receptor-deficient mice. mBio. 2019;10:e02298–19. doi: 10.1128/mBio.02298-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1993;92:883–893. doi: 10.1172/JCI116663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Pontarollo G, Kiouptsi K, Reinhardt C. A holobiont view on thrombosis: unravelling the microbiota’s influence on arterial thrombus growth. Microb Cell. 2020;7:28–31. doi: 10.15698/mic2020.01.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rune I, Rolin B, Larsen C, Nielsen DS, Kanter JE, Bornfeldt KE, Lykkesfeldt J, Buschard K, Kirk RK, Christoffersen B, et al. Modulating the gut microbiota improves glucose tolerance, lipoprotein profile and atherosclerotic plaque development in ApoE-deficient mice. PLoS One. 2016;11:e0146439. doi: 10.1371/journal.pone.0146439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wright SD, Burton C, Hernandez M, Hassing H, Montenegro J, Mundt S, Patel S, Card DJ, Hermanowski-Vosatka A, Bergstrom JD, et al. Infectious agents are not necessary for murine atherogenesis. J Exp Med. 2000;191:1437–1442. doi: 10.1084/jem.191.8.1437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Teupser D, Persky AD, Breslow JL. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler Thromb Vasc Biol. 2003;23:1907–1913. doi: 10.1161/01.ATV.0000090126.B1. [DOI] [PubMed] [Google Scholar]
  • 24.Mansukhani NA, Wang Z, Shively VP, Kelly ME, Vercammen JM, Kibbe MR. Sex differences in the LDL receptor knockout mouse model of atherosclerosis. Artery Res. 2017;20:8–11. doi: 10.1016/j.artres.2017.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Metchtnikoff E. The prolongation of life. Optimistic studies. New York (NY (USA)): G. P. Putnam’s Sons, Andesite Press; 2003. 31. [Google Scholar]
  • 26.Ghosh SS, Bie J, Wang J, Ghosh S.. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice – role of intestinal permeability and macrophage activation. PLoS One. 2014;9:e108577. doi: 10.1371/journal.pone.0108577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Le Roy T, Lecuyer E, Chassaing B, Rhimi M, Lhomme M, Boudebbouze S, Ichou F, Barcelo JH, Huby T, Guerin M, et al. The intestinal microbiota regulates host cholesterol homeostasis. Biol BMC. 2019;17:94. doi: 10.1186/s12915-019-0715-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Brandsma E, Kloosterhuis NJ, Koster M, Dekker DC, Gijbels MJJ, van der Velden S, Rios-Morales M, MJR van Faassen, Loreti MG, de Bruin A, et al. A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis. Res Circ. 2019;124:94–100. doi: 10.1161/CIRCRESAHA.118.313234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Madsen D, Beaver M, Chang L, Bruckner-Kardoss E, Wostmann B. Analysis of bile acids in conventional and germfree rats. J Lipid Res. 1976;17:107–111. [PubMed] [Google Scholar]
  • 30.Wostmann BS. Intestinal bile acids and cholesterol absorption in the germfree rat. J Nutr. 1973;103:982–990. doi: 10.1093/jn/103.7.982. [DOI] [PubMed] [Google Scholar]
  • 31.Gustafsson BE, Angelin B, Einarsson K, Gustafsson JA. Effects of cholesterol feeding on synthesis and metabolism of cholesterol and bile acids in germfree rats. J Lipid Res. 1977;18:717–721. [PubMed] [Google Scholar]
  • 32.Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, Felin J, Perkins R, Borén J, Oresic M, et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res. 2010;51:1101–1112. doi: 10.1194/jlr.M002774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wahlström A, Sayin SI, Marschall HU, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41–50. doi: 10.1016/j.cmet.2016.05.005. [DOI] [PubMed] [Google Scholar]
  • 34.Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576–585. doi: 10.1038/nm.3145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Caligiuri G, Nicoletti A, Zhou X, Törnberg I, Hansson GK. Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis. 1999;145:301–308. doi: 10.1016/S0021-9150(99)00081-7. [DOI] [PubMed] [Google Scholar]
  • 36.Hatch NW, Srodulski SJ, Chan HW, Zhang X, Tannock LR, King VL. Endogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein-receptor-deficient mice. Gend Med. 2012;9:319–328. doi: 10.1016/j.genm.2012.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kelly TN, Bazzano LA, Ajami NJ, He H, Zhao J, Petrosino JF, Correa A, He J. Gut microbiome associates with lifetime cardiovascular disease risk profile among Bogalusa heart study participants. Circ Res. 2016;119:956–964. doi: 10.1161/CIRCRESAHA.116.309219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fåk F, Tremaroli V, Bergström G, Bäckhed F. Oral microbiota in patients with atherosclerosis. Atherosclerosis. 2015;243:573–578. doi: 10.1016/j.atherosclerosis.2015.10.097. [DOI] [PubMed] [Google Scholar]
  • 39.Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163:1585–1595. doi: 10.1016/j.cell.2015.11.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kiouptsi K, Ruf W, Reinhardt C. Microbiota-derived trimethylamine. Circ Res. 2018;123:1112–1114. doi: 10.1161/CIRCRESAHA.118.314039. [DOI] [PubMed] [Google Scholar]
  • 41.Gregory JC, Buffa JA, Org E, Wang Z, Levison BS, Zhu W, Wagner MA, Bennett BJ, Li L, DiDonato JA, et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem. 2015;290:5647–5660. doi: 10.1074/jbc.M114.618249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Lehr HA, Sagban TA, Ihling C, Zähringer U, Hungerer KD, Blumrich M, Reifenberg K, Bhakdi S. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation. 2001;104:914–920. doi: 10.1161/hc3401.093153. [DOI] [PubMed] [Google Scholar]
  • 43.Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest. 2005;115:3149–3156. doi: 10.1172/JCI25482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008;8:802–815. doi: 10.1038/nri2415. [DOI] [PubMed] [Google Scholar]
  • 45.Balmer ML, Schürch CM, Saito Y, Geuking MB, Li H, Cuenca M, Kovtonyuk LV, McCoy KD, Hapfelmeier S, Ochsenbein AF, et al. Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling. J Immunol. 2014;193:5273–5283. doi: 10.4049/jimmunol.1400762. [DOI] [PubMed] [Google Scholar]
  • 46.Hergott CB, Roche AM, Tamashiro E, Clarke TB, Bailey AG, Laughlin A, Bushman FD, Weiser JN. Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis. Blood. 2016;127:2460–2471. doi: 10.1182/blood-2015-10-675-173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sano H, Sudo T, Yokode M, Murayama T, Kataoka H, Takakura N, Nishikawa SI, Kita T. Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation. 2001;103:2955–2960. doi: 10.1161/01.CIR.103.24.2955. [DOI] [PubMed] [Google Scholar]
  • 48.Inoue S, Orimo A, Hosoi T, Matsuse T, Hashimoto M, Yamada R, Ouchi Y, Orimo H, Muramatsu M. Expression of follistatin, an activin-binding protein, in vascular smooth muscle cells and atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1993;13:1859–1864. doi: 10.1161/01.atv.13.12.1859. [DOI] [PubMed] [Google Scholar]
  • 49.Porokuokka LL, Virtanen HT, Lindén J, Sidorova Y, Danilova T, Lindahl M, Saarma M, Andressoo J-O. Gfra1 underexpression causes Hirschsprung’s disease and associated enterocolitis in mice. Cell Mol Gasteroenterol Hepatol. 2019;7:655–678. doi: 10.1016/j.jcmgh.2018.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Chen W, Yu F, Di M, Li M, Chen Y, Zhang Y, Liu X, Huang X, Zhang M. MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells. Atherosclerosis. 2018;277:98–107. doi: 10.1016/j.atherosclerosis.2018.08.034. [DOI] [PubMed] [Google Scholar]
  • 51.Assarsson E, Lundberg M, Holmquist G, Björkesten J, Bucht Thorsen S, Ekman D, Eriksson A, Rennel Dickens E, Ohlsson S, Edfeldt G, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9:e95192. doi: 10.1371/journal.pone.0095192. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material

Articles from Gut Microbes are provided here courtesy of Taylor & Francis

RESOURCES